Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
Clinical trial NCT03923179 · UNKNOWN
Trial details
- NCT number
- NCT03923179
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2021-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.